No insider purchase over the last 90 days. The latest was filed 15 Dec 2025.
Every trade that managers of Amcor plc disclose to SEC (Form 4) is tracked on this page. The company sits in the Chemicals & Materials sector. From 18 October 2025 to 18 October 2026, the disclosure feed for Amcor plc logged 64 filings by 18 insiders.
Purchases and sales both appear in the filings: 5 purchases (5 insiders, €1.9M) and 3 sales (2 insiders, €123k). Taken together, the purchases exceed the sales by €1.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 3 senior executives, 1 finance chief and 1 chief executive among the declarants. Scherger Stephen R. filed the largest purchase, €861k, on 15 December 2025.
With 64 filings in twelve months, the company is more active than the median of 19 filings across the 5,808 companies we follow on the same exchange. Our records for Amcor plc go back to 2021, with 14 purchases and 40 sales on the open market in total. For the fiscal year to 30 June 2026, the annual 10-K puts revenue at 23.51 bn USD and net income at 1.11 bn USD, and the dividend at 2.59 USD per share.
In the case of 5 purchases, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase dates back some time: it was published 307 days ago, on 15 December 2025. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction.
Other companies in the same sector with recent insider buying flagged by our signals: Culp Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
+5 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Amcor plc Buy (bullish), based on 12 analysts. Average price target: US$49.76.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2026 · cache
25 of 251 declarations
Amcor plc is a global packaging leader serving consumer, food, beverage and healthcare markets. The company is listed in the United States on the NYSE under the ticker AMCR, which makes it directly relevant for investors tracking SEC filings, including Form 4 insider transactions. Amcor is headquartered operationally in Zurich, Switzerland, while its industrial footprint and customer base span North America, Europe, Asia-Pacific and emerging markets. Its competitive appeal comes from scale, technical expertise, close customer relationships and a long-running focus on packaging solutions that are lighter, more efficient and more recyclable. ([amcor.com](https://www.amcor.com/media/news/amcor-completes-one-for-five-reverse-stock-split?utm_source=openai))
From a business-model perspective, Amcor’s roots go back to its historic packaging and paper heritage, but the modern company has been reshaped through decades of industrial consolidation and portfolio expansion. Today it positions itself as a responsible packaging specialist with two core platforms: flexible packaging and rigid packaging, plus specialized solutions for healthcare and pharmaceuticals. That mix gives the group exposure to relatively defensive end markets where packaging is a mission-critical, recurring spend item. Amcor’s public positioning emphasizes innovation, global manufacturing reach and application-specific packaging science rather than commodity packaging alone. ([amcor.com](https://www.amcor.com/about?utm_source=openai))
Its product range is broad. In flexible packaging, Amcor supplies films, pouches, wraps and high-barrier structures for food, beverages, home and personal care, pet care and technical applications. In rigid packaging, it offers bottles, jars, containers, closures, cups, trays and related systems. In healthcare, the company develops sterile barrier systems, thermoformed packaging and recycle-ready solutions for medical and pharmaceutical customers. Amcor also highlights branded sustainable platforms such as AmPrima™, AmLite, AmFiber™ and AmSky®, which are designed to improve recyclability, reduce material use or replace harder-to-recycle structures. ([amcor.com](https://www.amcor.com/products?utm_source=openai))
In competitive terms, Amcor’s moat is built on scale, technical service and the ability to embed itself in customers’ supply chains across geographies and categories. The company’s recent news flow has been dominated by strategic execution and industrial investment. In January 2026, Amcor completed a 1-for-5 reverse stock split on the NYSE. During 2025, it announced North American capacity investments, including a major protein-packaging expansion and upgrades to post-consumer recycled packaging capability. It also continued to advance the integration/combination with Berry Global, a transaction expected to strengthen its portfolio and especially its polyethylene shrink capabilities. ([amcor.com](https://www.amcor.com/media/news/amcor-completes-one-for-five-reverse-stock-split?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 34 filings published between 28 August and 8 October 2026: no open-market purchase or sale filed by an insider. 34 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Jun 2026 | 23.51 bn USD | 1.11 bn USD | 2.38 USD | 2.59 USD | 10-K |
| Jun 2025 | 15.01 bn USD | 511.0 m USD | 1.60 USD | 2.54 USD | 10-K |
| Jun 2024 | 13.64 bn USD | 730.0 m USD | 2.52 USD | 2.49 USD | 10-K |
| Jun 2023 | 14.69 bn USD | 1.05 bn USD | 0.70 USD | 0.49 USD | 10-K |
| Jun 2022 | 14.54 bn USD | 805.0 m USD | 0.53 USD | 0.48 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.